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Losartan potassium (LOS), amlodipine besilate (AML) and hydrochlorothiazide
(HYD) are drugs widely used for the treatment of hypertension and cardiovascular dis-
eases in combined pharmaceutical preparations. Losartan potassium and its principal
active metabolites block the vasoconstrictor and aldosterone-secreting effects of angio-
tensin II by selectively blocking the binding of angiotensin II to angiotensin II receptor
type 1 (AT1) receptor found in many tissues (vascular smooth muscle, adrenal gland).
Amlodipine besilate inhibits the movement of calcium ions across the cell membrane
into vascular smooth muscles and myocytes. Action is stronger in arterial resistance ves-
sels causing peripheral vasodilatation and reduction in afterload. Hydrochlorothiazide
inhibits the reabsorption of sodium and chloride at the beginning of the distal convo-
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In the present work, four different spectrophotometric
methods for simultaneous estimation of losartan potas-
sium, amlodipine besilate and hydrochlorothiazide in raw
materials and in formulations are described. Overlapped
data was quantitatively resolved by using chemometric
methods, classical least squares (CLS), multiple linear re-
gression (MLR), principal component regression (PCR)
and partial least squares (PLS). Calibrations were construc-
ted using the absorption data matrix corresponding to
the concentration data matrix, with measurements in the
range of 230.5–350.4 nm (Dl = 0.1 nm) in their zero order
spectra. The linearity range was found to be 8–40, 1–5 and
3–15 mg mL–1 for losartan potassium, amlodipine besi-
late and hydrochlorothiazide, respectively. The validity
of the proposed methods was successfully assessed for
analyses of drugs in the various prepared physical mix-
tures and in tablet formulations.
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luted tubule. It causes natriuretic effect mainly by decreasing sodium and chloride reab-
sorption in the cortical segment of the ascending limb of the loop of Henley by inhibi-
tion of a specific Na+,Cl– co-transporter (1).
A few estimations in body fluids, in bulk in combination with other drugs and in
single dosage forms have been reported for losartan potassium, amlodipine besilate and
hydrochlorothiazide such as HPLC (2–7), spectrophotometry (8), multivariate approach
(9), multi-syringe chromatography (MSC) (10) and HPTLC (11, 12), ultra performance
liquid chromatography (UPLC-MS) (13). All these drugs are available in combined tab-
let dosage forms, as antihypertensive agents. An extensive literature survey revealed
that a number of methods are reported for the individual drugs but there is no report on
simultaneous estimation of such a combination in physical mixtures or in pharmaceuti-
cal formulations by chemometric methods. The present article discusses the attempts
made to develop simple, sensitive and reproducible methods for simultaneous estima-
tion of these drugs in dosage forms.
Chemometric calibration techniques in spectral analysis are widely used in the
quality control of drugs in mixtures and pharmaceutical formulations containing two or
more drugs with overlapping spectra where separation procedures are not required in
drug determination. We have also used these techniques for simultaneous analyses of
mixtures (14–19).
In this study, four chemometric methods for spectral data processing are proposed




A Shimadzu (Japan) 2550-double beam spectrophotometer was used for all spectro-
photometric measurements. Absorption spectra of the reference and test solutions were
taken in 1-cm matched quartz cells over the range of 200–400 nm. Chemometric calcula-
tions on the resulting data were carried out with the PLS toolbox (Demover5.0) in
MATLAB 7 (Math works).
Samples and solvents
Losartan potassium, amlodipine besilate and hydrochlorothiazide were kindly sup-
plied by ATOZ India Ltd., India, and were certified to be 99.8, 99.6 and 99.9 % pure, re-
spectively. The drugs were used without further purification. All the solvents used in
spectrophotometric analysis were of analytical reagent grade. Trilopace tablets, batch
number BF 70002 (Akums Drugs & Pharmaceuticals Ltd., India), which were claimed to
contain 50 mg of losartan potassium USP, 5 mg of amlodipine besilate BP and 12.5 mg of
hydrochlorothiazide IP, were used.
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Standard solutions and mixtures
Stock solutions of LOS (1 mg mL–1), AML (1 mg mL–1) and HYD (2 mg mL–1) in
methanol were diluted with water to prepare the working solutions (0.16 mg mL–1, 0.02
mg mL–1 and 0.06 mg mL–1, respectively). The calibration set contained 25 and the pre-
diction set 9 mixtures of calibration samples, so that the concentration of each drug in
the resulting solutions was in its own linear dynamic range, as shown in Table 1. Fur-
thermore, we demonstrated that in formulations LOS, AML and HYD range 1: 2.5: 10.
Tablet analysis
Twenty tablets were weighed accurately and powdered. An amount of the powder
equivalent to 50 mg of AML, 125 mg of HYD and 500 mg of LOS was dissolved in 50 mL
of methanol. The solution was ultrasonicated for 10 minutes. Then, the solution was fil-
tered through Whatman filter paper No. 41. The filtrate (3 mL) was transferred into a
100 mL volumetric flask and made up to volume with Millipore water. Aliquots of these
solutions were used in such a way that the concentration of each drug was within the
range of the calibration matrix. The diluted solutions were analyzed six times. All the
proposed chemometric methods were applied.
Chemometric methods
Classical least squares (CLS). – This method assumes Beer’s law model with the
absorbance at each frequency being proportional to the component concentration. In
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Table I. Composition of the calibration set
Concentration (mg mL–1) Concentration (mg mL–1)
Mixture LOS AML HYD Mixture LOS AML HYD
1 24 3 9 14 24 5 15
2 24 1 3 15 40 5 3
3 8 1 15 16 40 1 12
4 8 5 6 17 8 4 3
5 40 2 15 18 32 1 9
6 16 5 9 19 8 3 12
7 40 3 6 20 24 4 12
8 24 2 6 21 32 4 6
9 16 2 12 22 32 2 3
10 16 4 15 23 16 1 6
11 32 5 12 24 8 2 9
12 40 4 9 25 16 3 3
13 32 3 15
LOS, AML, HYD – losartan potassium, amlodipine besilate, hydrochlorothiazide, respectively.
matrix notation, Beer’s law model for m calibration standards containing l chemical
components with the spectra of n digitized absorbances is given by:
A = C ´ K + EA (1)
where A is the m ´ n matrix of calibration spectra, C is the m ´ l matrix of component
concentration, K is the l ´ n matrix of absorptivity-path length products, and EA is the
m ´ n matrix of spectral errors. K then represents the matrix of pure component spectra
at unit path length. The classical least squares solution according to Eq. (1) during cali-
bration is:
K (C C) C A= ×−T 1 T (2)
where K indicates the least-squares estimation of K.
Analysis based on spectrum a, of unknown component concentration (sample):
C0 = ×
−( ) 1  KK K aT (3)
where C0 is vector of predicted concentration and KT is the transpose of matrix K.
Multiple linear regressions (MLR). – If absorbance measurements for several solutions
containing mixtures of the analytes are made in numbers exceeding the number of mix-
ture components, then the system composed of the absorbance and concentration matri-
ces will be overdimensioned and take the following matrix form:
A = KC (4)
where A is the data absorbance calibration matrix, K is the matrix from which the pro-
portionality constants are calculated from spectra for standard solutions of pure analy-
tes and/or their mixtures, and C is the concentration matrix. The C prediction concentra-
tion matrix can be calculated from the following equation:
C = (KTK)–1 KT (5)
where K’ is the transpose of K and A is the absorbance matrix of unknown samples. Ma-
trix K can be obtained in various ways. We calculated K values by MLR of the data for
mixtures of analytes of known composition (20).
Principle component regression (PCR). – In the spectral work, the following steps can
explain the fundamental concept of PCR. The original data obtained in absorbances (A)
and concentrations (C) of analytes were reprocessed by mean-centring as A0 and C0, re-
spectively. Using the ordinary linear regression:
C = a + b ´ A (6)
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The coefficient b is: b = P ´ q, where P is the matrix of eigenvectors and q is the
C-loadings given by q = D ´ TT ´ A0. Here, TT is the transpose of the score matrix T. D is
a diagonal matrix having on components the inverse of the selected eigenvalues.
Knowing b one can easily find a by using the formula a = Cmean ´ ATmean ´ b, where
ATmean represents the transpose of the matrix having the entries of the mean absorbance
values, and Cmean is the mean concentration of the calibration set.
Partial least squares (PLS). – In the UV-Vis spectra, the absorbance data (A) and con-
centration data (C) are mean centered to give the data matrix A0 and vector C0. The


































The matrix and vector of the residuals in A0 and C0 are:
A A t P1 0 1 1
T= − (11)
C C t q1 0 1 1
T= − (12)
From the general linear equation, the regression coefficients were calculated by:
b = W(PTW)-1q (13)
a = Cmean – ATmeanb (14)
The built calibration equation is used for the estimation of the compounds in the
samples (21).
145
D. Nagavalli et al.: Simultaneous spectrophotometric determination of losartan potassium, amlodipine besilate and hydrochlorothiazide in
pharmaceuticals by chemometric methods, Acta Pharm. 60 (2010) 141–152.
RESULTS AND DISCUSSION
A calibration set was randomly prepared as mixtures of LOS, AML and HYD in
their possible compositions by applying a multilevel multifactor design (22) (Table I).
The UV absorbance data were obtained by measuring the absorbances in the region of
200–400 nm (Fig. 1). From this 230.5–350.4 nm wavelength was selected for construction
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Amlodipine besilate (5 g mL )m
–1
Hydrochlorothiazide (15 g mL )m
–1
Losartan potassium (40 g mL )m
–1
200 220 240 260 280 300 320 340 360 380 400Fig. 1. Overlapping spectrum of LOS, AML
and HYD.
Table II. Statistical parameters of chemometric methods in the calibration set
Method Parameter LOS AML HYD
CLS
RMSECV 0.1647 0.1183 0.1823
RMSEP 0.1264 0.0908 0.1110
R 1 0.9940 0.9990
MLR
RMSECV 0.2258 0.2047 0.2583
RMSEP 0.2062 0.0908 0.2328
R 1 0.9920 0.9980
PCR
RMSEC 0.1647 0.1183 0.1823
RMSECV 0.1987 0.1424 0.2134
RMSEP 0.1250 0.0856 0.1120
R 1 0.9940 0.9990
PLS
RMSEC 0.1647 0.1183 0.1823
RMSECV 0.1987 0.1424 0.2134
RMSEP 0.1250 0.0856 0.1120
R 1 0.9940 0.9990
CLS – classical least squares, MLR – multiple linear regression, PCR – principal component regression.
PLS – partial least squares, RMSEP – root mean square error of prediction, RMSECV – root mean square error
of cross validation, RMSEC – root mean square error of calibration.
For other acronyms see Table I.
of the calibration model. The fit model was constructed by using the absorption data
matrix corresponding to the concentration data matrix in CLS, MLR, PCR and PLS.
Before constructing the model, pre-processing (23) was carried out to reduce the ef-
fect of noise, improve the predictive ability of the model and simplify the model by mak-
ing the data more normally distributed and the wavelength selection based on the best
outcome for reduced error of spectral data. In Table II, R is defined as the correlation co-
efficient between constituent concentrations and shows the absorbance effects relating to
the constituent of interest. Values obtained in the methods close to 1 mean no interfer-
ence was coming from other constituents in the respective set of calibration mixtures.
The most commonly employed validation criterion is to divide the dataset into two
subsets, a calibration set and a validation set. The calibration model is calculated using
the calibration set. Then, the root mean square errors of calibration and validation,
RMSEC – root mean square error of calibration and RMSECV – root mean square error
of cross validation, are calculated by using the calibration model under investigation to









Selection of the optimum number of factors for PCR and PLS. – For PCR and PLS meth-
ods, 25 calibration spectra were used for the selection of the optimum number of factors
by using the cross-validation with the leave-out-one technique. This allows modelling of
the system with the optimum amount of information and avoidance of over-fitting or
under-fitting. The cross-validation procedure consisted of systematically removing one
of a group of training samples in turn and using only the remaining ones for the con-
struction of latent variable factors and applied regression. The predicted concentrations
were then compared with the actual ones for each of the calibration samples and the
root mean square error of prediction (RMSEP) was calculated. The RMSEP was compu-
ted in the same manner each time, and then a new factor was added to the PCR and PLS
model. The selected model was that with the smallest number of factors such that its
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Fig. 2. Representation of RMSECV values
generated from calibration by PCR: LOS,
AML and HYD.
RMSECV values were not significantly greater than that for the model, which yielded
the minimum RMSECV. A plot of RMSECV values against the number of components
(Figs. 2 and 3) indicates that the latent variable factor 3 was optimum for PCR and PLS
selected based on the RMSEC and RMSECV, respectively, for the estimation of the titled
drugs. At the selected principal component of PCR and PLS, the concentrations of each
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Fig. 3. Representation of RMSECV values
generated from calibration by PLS: LOS,
AML and HYD.
Table III. Composition of synthetic mixtures (formulation) and recovery set
Synthetic formulation (mg mL–1)a Formulation (mg mL–1)b Recovery (mg mL–1)c
LOS AML HYD LOS AML HYD LOS AML HYD
24.8 3.6 10.8 30 3 7.5 3 0.45 0.75
24.8 1.2 3.6 30 3 7.5 3 0.45 0.75
9.6 1.2 18.0 30 3 7.5 3 0.45 0.75
9.6 6.0 7.2 30 3 7.5 6 0.90 1.50
48.0 2.4 18.0 30 3 7.5 6 0.90 1.50
19.2 6.0 10.8 30 3 7.5 6 0.90 1.50
48.0 3.6 7.2 30 3 7.5 9 1.35 2.25
28.8 2.4 7.2 30 3 7.5 9 1.35 2.25
19.2 2.4 14.4 30 3 7.5 9 1.35 2.25
a Synthetic mixture of LOS, AML and HYD (standards).
b Pharmaceutical formulation, tablet.
c Recovery – standard addition to pharmaceutical formulation..
For other acronyms see Table I.
In order to test the proposed techniques, the validation set of synthetic mixtures
(from standards) containing the three drugs (Table III) in variable ratios was carried out;
the results are given in Table IV. The maximum values of the mean percent errors corre-
sponding to CLS, MLR, and PCR and PLS for the same mixtures were completely ac-
ceptable because of their very small numerical values (below 0.2). Results of tablet analy-
ses are shown in Table V.
Recovery and precision studies
To check the validity of the proposed methods, recovery studies were carried out by
addition of the standard to the preanalyzed formulation. Results of recovery studies were
found to be from 99.3 ± 0.3 to 101.3 ± 0.6 % (Table VI). Good precision of the method was
indicated by RSD ranging 0.3–1.4 %.
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Table V. Prediction results for losartan, amlodipine and hydrochlorothiazide in formulation samples by
different chemometric methods
Method Parametera LOS AML HYD
CLS
Mean (%) 100.02 100.39 101.28
RSD (%) 0.034 0.720 0.131
MLR
Mean (%) 100.27 98.92 101.52
RSD (%) 0.078 1.683 1.192
PCR
Mean (%) 100.01 100.36 101.32
RSD (%) 0.033 0.705 0.128
PLS
Mean (%) 100.01 100.36 101.32
RSD (%) 0.033 0.705 0.128
a Nine determinations.
Table IV. Prediction results for losartan, amlodipine and hydrochlorothiazide from the synthetic validation
samples by different chemometric methods
Component
CLS MLR PCR PLS
Mean ± SDa Mean ± SDa Mean ± SDa Mean ± SDa
LOS 100.6 0.9 100.4 1.2 100.6 0.9 100.6 0.9
AML 100.0 1.6 100.6 0.7 100.0 0.5 100.0 0.5
HYD 100.9 0.6 99.7 0.9 100.9 0.7 100.9 0.7
a Nine determinations.
For acronyms see Table I and II.
CONCLUSIONS
Based on the results obtained in this work, the UV spectrophotometric method for
simultaneous determination of losartan potassium, amlodipine besilate and hydrochlo-
rothiazide in mixtures by multivariate calibration of synthetic and pharmaceutical sam-
ples is applicable. PLS and PCR using a calibration matrix constructed with absorption
spectra were successfully applied to simultaneous analysis of these drugs in synthetic
and pharmaceutical mixtures.
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3 33.1 100.4 0.5 3.4 99.8 0.8 8.4 101.6
6 36.0 100.0 0.9 3.9 99.2 1.5 9.1 100.6
9 39.0 100.1 1.4 4.3 99.4 2.3 9.9 101.6
Mean 100.1 99.5 101.3
S.D ± 0.2 ± 0.3 ± 0.6
MLR
3 33.0 100.1 0.5 3.5 101.3 0.8 8.4 102.2
6 35.7 99.3 0.9 3.9 99.9 1.5 9.1 100.6
9 39.1 100.2 1.4 4.4 100.5 2.3 9.8 100.3
Mean 99.9 100.5 101.0
S.D ± 0.7 ± 1.0 ± 1.4
PCR
3 33.1 100.3 0.5 3.4 99.8 0.8 8.4 101.7
6 36.0 100.0 0.9 3.9 99.0 1.5 9.1 100.6
9 39.0 100.0 1.4 4.3 99.2 2.3 9.9 101.6
Mean 100.1 99.3 101.3
S.D ± 0.2 ± 0.4 ± 0.6
PLS
3 33.1 100.3 0.5 3.4 99.7 0.8 8.4 101.7
6 36.0 100.0 0.9 3.9 99.0 1.5 9.1 100.6
9 39.0 100.0 1.4 4.3 99.2 2.3 9.9 101.6
Mean 100.1 99.3 101.3
S.D ± 0.2 ± 0.4 ± 0.6
a Additions to 30 mg mL–1 LOS, 3 mg mL–1 AML and 7.5 mg mL–1 HYD in the formulation.
b Nine determinations.
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S A @ E T A K
Istodobno spektrofotometrijsko odre|ivanje losartan kalija, amlodipin besilata
i hidroklorotiazida u farmaceutskim pripravcima kemometrijskom metodom
D. NAGAVALLI, V. VAIDHYALINGAM, A. SANTHA, A. S. K.SANKAR i O. DIVYA
U radu su opisane ~etiri spektrofotometrijske metode za istodobno odre|ivanje lo-
sartan kalija, amlodipin besilata i hidroklorotiazida u sirovinama i farmaceutskim pri-
pravcima. Podaci koji su se preklapali kvantitativno su razlu~eni kemometrijskim meto-
dama, klasi~nom metodom najmanjih kvadrata (CLS), multiplom linearnom regresijom
(MLR), regresijom glavnih komponenata (PCR) te metodom parcijalnih najmanjih kva-
drata (PLS). Kalibracije su provedene koriste}i podatke o ovisnosti apsorpcije o kon-
centracijama, mjere}i spektre nultog reda u rasponu 230,5–350,4 nm (Dl = 0,1 nm). Li-
nearnost za losartan kalij bila je 8–40, za amlodipin besilat 1–5, a za hidroklorotiazid
3–15 mg mL–1. Valjanost predlo`enih metoda uspje{no je potvr|ena analizom navedenih
lijekova u razli~itim pripremljenim smjesama i tabletama.
Klju~ne rije~i: losartan, amlodipin besilat, hidroklorotiazid, spektrofotometrija, kemometrija
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